Comment
0
Tweet
0
Print
RSS Feeds

Roche to buy molecular diagnostics company IQuum

Monday - 4/7/2014, 7:50am  ET

GENEVA (AP) -- Swiss drug maker Roche plans to buy IQuum, Inc., a U.S. company that specializes in molecular diagnostics and sample testing, in a deal worth up to $450 million.

Roche said Monday that it will pay $275 million upfront for the privately held IQuum, based in Marlborough, Massachusetts. It said further payments of up to $175 million are dependent on "product-related milestones."

Once the acquisition is complete, Roche plans to integrate IQuum into its Roche Molecular Diagnostics division.


Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.